Skip to main
NNOX

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging is well-positioned to drive the world's transition to preventive health care with its integrated, cost-effective, and AI-based medical imaging platform. With a growing national footprint and partnerships with established regional players, the company has a strong potential for revenue growth, especially in the lucrative orthopedic market. Its DTS imaging is also reimbursable under an existing CPT code, making it easier for practices to adopt the technology.

Bears say

Nano X Imaging is facing significant challenges as they struggle to convert their U.S. distribution agreements into revenue, while also acknowledging the need for additional financing. It will be crucial for the company to demonstrate successful execution of their partnership-driven approach through new distribution agreements, initial system deployments, and increasing utilization at installed sites in order to drive meaningful revenue growth and validate their commercial model. Additionally, the company's shift towards a more outsourced manufacturing model may help to reduce capital intensity but comes with its own risks and costs.

Nano-X Imaging (NNOX) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Buy based on their latest research and market trends.

According to 2 analysts, Nano-X Imaging (NNOX) has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.